Liver specialists in Dallas, Fort Worth and Plano provide comprehensive liver disease diagnosis and advanced treatment
Our 12 liver outreach clinics located throughout Texas, bring specialized liver care to patients closer to home. Our hepatologists travel to the outreach clinics as often as three times a month to see patients with viral hepatitis, cirrhosis, liver masses and other general liver conditions.
Baylor Scott & White has established agreements with several types of insurances in an effort to make sure your health needs are covered.
Aetna - (2)Aetna Signature AdministratorsMedicare Advantage Plans
Blue Cross Blue Shield - (9)Blue EssentialsBlue PremierParPlanBlue Advantage HMOBlue Choice PPOBlue Premier Open Access HMOIndemnityMedicare Advantage - OncorTraditional
Cigna - (4)LocalPlusOpen Access PlusChildren's Medical Center Employee PlanCity of Dallas Employee Plan
DFW ConnectedCare - (1)American Airlines Employee Benefit Plan
HealthSmart - (2)ACCEL NetworkPreferred Network
Humana - (4)ChoiceCareNational POSHumana PreferredCommercial PPO Plans
Superior - (1)STAR+PLUS
Superior HealthPlan - (3)STAR+PLUSMedicare/Medicaid Dual Needs Plan: Advantage HMO SNPMedicare/Medicaid Plan
Healthscope - (2)DART ACO FlexDART ACO Flex Plus
Parkland Community Health Plan - (2)CHIP MedicaidHealthFirst Medicaid
Scott & White Health Plan - (16)2019 BSWH Employee Network - PPO & HSA2019 BSWH Employee Network - SEQA & EQACigna PPO Network - Out-of-Area Member PlanEPO Network - GroupEPO Network - Individual/FamilyHMO Network - GroupHMO Network - Individual/FamilyMcLane Group NetworkPHCS/ARGUS - PPO Network - Out-of-Area Member PlanPPO Choice NetworkPPO Choice Preferred NetworkPPO Network - GroupSeniorCare Advantage HMOSeniorCare Advantage PPOTexas Statewide PPOTRS - Active Care Participants Network
UnitedHealth - (2)Nexus ACO OANexusACO R
University Mary Hardin-Baylor - (1)Employee Benefit Plan
We couldn’t find any results for ""
- Acute liver failure
- Alcohol-related liver disease
- Alpha-1-antitrypsin deficiency
- Fatty liver disease
- Liver cancer
- Liver disease
- Nonalcoholic fatty liver disease
- Portal vein thrombosis
- Primary biliary cholangitis (PBC)
- Primary sclerosing cholangitis (PSC)
- Toxic (drug-induced) liver injury
- Wilson’s disease
Other payment options:
At Baylor Scott & White Health, we want to be a resource for you and your family. Our team of customer service representatives and financial counselors are here to help you find financial solutions that can help cover your cost of care. We encourage you to speak to a member of our team at any time before, during or after care is received.
To ensure that your visit to our office is as convenient and efficient as possible, we are pleased to offer our registration forms online. The patient registration form may be completed electronically and printed for better legibility or completed manually.
New medicine could melt away fat
A new therapy that could revolutionize how fatty liver disease is managed.
James Trotter, MD, Medical Director, Transplant Hepatology at Baylor University Medical Center is one of the chief investigators of a new therapy that could revolutionize how fatty liver disease is managed. According to the American Liver Foundation, 60 million Americans are living with nonalcoholic steatohepatitis (NASH) which is a part of a group of conditions that lead to fat buildup in the liver, inflammation and fibrosis. Early results were just published in The Lancet, one of the highest ranked medicine journals in the world.Read Article
Reducing barriers to living donor transplantation
This pilot study aims to determine how living donor transplant candidates fare after transplant. Data collection began in April 2018 and will continue over the next two years to provide people considering donating more detailed information about the long-term benefits and risks of living donation.
Baylor University Medical Center is one of 16 sites nationwide participating in a pilot study to determine how living donor transplant candidates fare after transplant, whether they actually donate or not. There are six liver transplant sites, including Baylor, and ten kidney programs participating in the study. The need for solid organ transplants is still growing but living donor transplants have actually declined from their peak in 2004. One of the major barriers to living organ donation is that long-term outcomes for donors are unclear. The Scientific Registry of Transplant Recipients (SRTR) has now launched the Living Donor Collective (LDC) to establish a living donor registry to study the long-term outcomes of living organ donation.
The goal of the project is to establish a living organ donor registry where all living donor candidates who are evaluated will be entered into a database. All aspects of their physical and psychosocial well-being will be tracked. The (LDC) will follow up approximately one year after the transplant surgery or a year after the decision not to donate. Donors and non-donors will be followed to monitor long-term outcomes of both groups. Ultimately, the research collected over the next two years will provide people considering donating more detailed information about the long-term benefits and risks of living donation.
In the wake of the opioid crisis, more donated organs are infected with the hepatitis C virus, and many are declined as a result. But a Tarrant County woman says she's proof that.
Infected organ saves life of Tarrant County woman